Efficacy and safety of bevacizumab combined with temozolomide in the treatment of recurrent malignant gliomas and its influence on serum tumor markers

CONCLUSIONS: BZ+TMZ is effective in treating recurrent malignant gliomas, which can improve the QoL and survival of patients.PMID:35035729 | PMC:PMC8748084
Source: American Journal of Translational Research - Category: Research Authors: Source Type: research